E

Editas Medicine (EDIT)

$000.00 0.00% ($0.00)

Today
Week
Month
Year
5 Year
YTD

baraka

getbaraka.com

About Editas Medicine (EDIT)

Editas Medicine, Inc. is a genome editing company. It is engaged in treating patients with genetically defined diseases by correcting their disease-causing genes. It operates through developing and commercializing genome editing technology segment. I... Read more

Open
USD2.84
High
USD2.89
Low
USD2.80
52 Week High
USD5.85
Monthly Return
31.50%
Revenue
36M

Daily Vol.
107.95k
Avg. Daily Vol.
2.97M
Market Cap.
241M
52 Week Low
0.91
Annual Return
-52.30%

Stock News

Retail sales snap back after tariffs are dialed down. Economy still expanding at decent pace.

Retail sales snap back after tariffs are dialed down. Economy still expanding at decent pace.

MarketWatch

Shares of high fructose syrup producer ADM tumble after Trump says Coca-Cola agrees to use real cane sugar

Shares of high fructose syrup producer ADM tumble after Trump says Coca-Cola agrees to use real cane sugar

CNBC

An Analysis Of Tariffs And Inflation: Why I'm Skeptical

An Analysis Of Tariffs And Inflation: Why I'm Skeptical

SeekingAlpha

Climbing Limo GDP Forecast For Q2 2025

Climbing Limo GDP Forecast For Q2 2025

SeekingAlpha

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.

Build Your Long Term Wealth

Build Your Long Term Wealth

A modern investment app with fair pricing.

Top Movers

This list tracks the stocks with the most upwards (top gainers) and downwards (top losers) movement in price from the previous day.

Not sure which stock to invest in?

Not sure which stock to invest in?

Get access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.